MeSH term
Frequency | Condition_Probility | Aged | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Humans | 19 | 0.0 |
Kallikreins/*biosynthesis | 2 | 33.0 |
Male | 8 | 0.0 |
Middle Aged | 4 | 0.0 |
Prognosis | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Base Sequence | 8 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Introns | 2 | 0.0 |
Kallikreins/*genetics | 6 | 24.0 |
Molecular Sequence Data | 8 | 0.0 |
Prostate-Specific Antigen/*genetics | 2 | 10.0 |
*Chromosomes, Human, Pair 19 | 3 | 0.0 |
DNA | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Comparative Study | 2 | 0.0 |
Female | 9 | 0.0 |
*Multigene Family | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Serine Endopeptidases/*genetics | 2 | 3.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
Alleles | 4 | 0.0 |
Animals | 3 | 0.0 |
Exons | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Genetic Markers/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Adult | 3 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Kidney/metabolism | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Mice | 2 | 0.0 |
Tissue Kallikreins | 2 | 4.0 |
Tumor Cells, Cultured | 3 | 0.0 |
